From: Remnant cholesterol is an effective biomarker for predicting survival in patients with breast cancer
excluding patients with underlying diseases | ||||
---|---|---|---|---|
 | Crude model | Adjusted model | ||
HR (95%CI) | p | HR (95%CI) | p | |
Continuous (n = 550) | 1.45 (1.16,1.82) | 0.001 | 1.38 (1.1,1.71) | 0.004 |
Cutoff value | Â | Â | Â | Â |
 C1 (≤ 0.82, n = 391) | Ref |  | Ref |  |
 C2 (> 0.82, n = 159) | 1.94 (1.27,2.99) | 0.002 | 1.81 (1.15,2.82) | 0.01 |
Tertiles | Â | Â | Â | Â |
 T1 (< 0.41, n = 202) | Ref |  | Ref |  |
 T2 (< 0.80, n = 180) | 1.42 (0.82,2.45) | 0.210 | 1.56 (0.91,2.7) | 0.109 |
 T3 (≥ 0.80, n = 168) | 2.09 (1.24,3.52) | 0.005 | 1.93 (1.13,3.28) | 0.016 |
p for trend | Â | 0.005 | Â | 0.015 |
excluding patients with short-term deaths (1-year) | ||||
---|---|---|---|---|
Continuous (n = 648) | 1.56 (1.2,2.02) | 0.001 | 1.51 (1.18,1.93) | 0.001 |
Cutoff value | Â | Â | Â | Â |
 C1 (≤ 0.82, n = 450) | Ref |  | Ref |  |
 C2 (> 0.82, n = 198) | 1.84 (1.17,2.9) | 0.009 | 1.97 (1.22,3.18) | 0.006 |
Tertiles | Â | Â | Â | Â |
 T1 (< 0.41, n = 218) | Ref |  | Ref |  |
 T2 (< 0.80, n = 220) | 1.31 (0.72,2.37) | 0.377 | 1.35 (0.74,2.48) | 0.324 |
 T3 (≥ 0.80, n = 210) | 1.89 (1.08,3.31) | 0.025 | 1.96 (1.1,3.49) | 0.023 |
p for trend | Â | 0.023 | Â | 0.022 |